摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

neopentyl bromoacetate | 101001-73-4

中文名称
——
中文别名
——
英文名称
neopentyl bromoacetate
英文别名
2,2-dimethylpropyl 2-bromoacetate
neopentyl bromoacetate化学式
CAS
101001-73-4
化学式
C7H13BrO2
mdl
——
分子量
209.083
InChiKey
YMFWXAPAYFRXMT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    181.6±8.0 °C(Predicted)
  • 密度:
    1.300±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    10
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    neopentyl bromoacetate 在 sodium carbonate 、 三乙胺三甲基膦 作用下, 以 二氯甲烷氯仿甲苯 为溶剂, 生成
    参考文献:
    名称:
    Phosphine-Catalyzed Synthesis of 1,3-Dioxan-4-ylidenes
    摘要:
    A phosphine-catalyzed reaction of an allenoate with aldehydes furnished (2,6-diaryl-[1,3]dioxan-4-ylidene)-acetates 4 in excellent to moderate yields with complete diastereoselectivity and high E/Z-selectivities. Upon removal of the acetal functionality in this domino reaction product 4, delta-hydroxy-beta-ketoester 11 was obtained. The reported vinylphosphonium-based approach provides a new way to achieve a synthesis of 6-hydroxy-beta-ketoesters that differs from the classical dianion-based approach.
    DOI:
    10.1021/ol050203y
  • 作为产物:
    参考文献:
    名称:
    Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics
    摘要:
    The optimization of the pharmacokinetic performance of various 2-pyridone-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors following oral administration to either beagle dogs or CM-monkeys is described. The molecules described in this work are composed of a 2-pyridone-containing peptidomimetic binding determinant and an alpha,beta-unsaturated ester Michael acceptor moiety which forms an irreversible covalent adduct with the active site cysteine residue of the 3C enzyme. Modification of the ester contained within these compounds is detailed along with alteration of the P-2 substituent present in the peptidomimetic portion of the inhibitors. The pharmacokinetics of several inhibitors in both dogs and monkeys are described (7 h plasma concentrations after oral administration) along with their human plasma stabilities, stabilities in incubations with human, dog, and monkey microsomes and hepatocytes, Caco-2 permeabilities, and aqueous solubilities. Compounds containing an alpha,beta-unsaturated ethyl ester fragment and either an ethyl or propargyl. P-2 moiety displayed the most promising combination of 3C enzyme inhibition (k(obs)/[1] 170 000-223 000 M-1 s(-1)), antiviral activity (EC50 = 0.047-0.058 muM, mean vs seven HRV serotypes), and pharmacokinetics following oral administration (7 h dog plasma levels = 0.248-0.682 muM; 7 h CM-monkey plasma levels = 0.057-0.896 muM).
    DOI:
    10.1021/jm030166l
点击查看最新优质反应信息

文献信息

  • Amine-catalyzed tunable reactions of allenoates with dithioesters: formal [4+2] and [2+2] cycloadditions for the synthesis of 2,3-dihydro-1,4-oxathiines and enantioenriched thietanes
    作者:Hai-Bin Yang、Yu-Chao Yuan、Yin Wei、Min Shi
    DOI:10.1039/c5cc01313e
    日期:——

    The chemoselective [4+2] vs. [2+2] cycloaddition between allenoates and dithioesters has been developed on the basis of switching the nucleophilic amine catalyst, offering a divergent synthesis of sulfur-containing heterocycles.

    已开发出基于切换亲核胺催化剂的烯酸酯和二硫酯之间的化学选择性[4+2] vs. [2+2]环加成反应,提供了含硫杂环化合物的分岔合成。
  • Prodrugs of thrombin inhibitors
    申请人:AstraZeneca AB
    公开号:US20040162410A1
    公开(公告)日:2004-08-19
    There is provided compounds of formula I, R 1 O(O)C—CH 2 —(R)Cgl-Aze-Pab-R 2 I wherein R 1 and R 2 have meanings given in the description, which are useful as prodrugs of inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (eg thrombosis) or as anticoagulants.
    提供了公式I,其中包含化合物,R1O(O)C—CH2—(R)Cgl-Aze-Pab-R2I,其中R1和R2的含义如说明中所述,这些化合物可用作类似胰蛋白酶的抑制剂的前药,如凝血酶,并且特别适用于治疗需要抑制凝血酶的情况(例如血栓形成)或作为抗凝剂。
  • Photocatalytic 1,2-oxo-alkylation reaction of styrenes with diazoacetates
    作者:Fang Li、Siqi Zhu、Rene M. Koenigs
    DOI:10.1039/d2cc02414d
    日期:——
    reactivity of diazoalkanes can be suppressed and a 1,2 oxo-alkylation reaction can be achieved (32 examples, up to 94% yield) without the formation of cyclopropane by-products via the formation of radical intermediates from ethyl diazoacetate.
    我们报告了苯乙烯与仅受体重氮烷的光催化 1,2-双官能化反应。在 DABCO 和t BuOOH 的存在下,可以抑制重氮烷烃的卡宾反应性,并且可以实现 1,2 氧代烷基化反应(32 个实例,高达 94% 的产率),而不会通过形成生成环丙烷副产物来自重氮乙酸乙酯的自由基中间体。
  • C‐H Functionalization of Heterocycles with Triplet Carbenes by means of an Unexpected 1,2‐Alkyl Radical Migration
    作者:Claire Empel、Sripati Jana、Łukasz Ciszewski、Katarzyna Zawada、Chao Pei、Dorota Gryko、Rene M. Koenigs
    DOI:10.1002/chem.202300214
    日期:——
    A triplet carbene is involved in the C3-H functionalization of indole heterocycles. We herein describe a combined experimental and computational study on this reaction and unveil an unexpected 1,2-alkyl radical migration pathway.
    三线态卡宾参与吲哚杂环的 C3-H 官能化。我们在此描述了对该反应的综合实验和计算研究,并揭示了一种意想不到的 1,2-烷基自由基迁移途径。
  • Prodrugs of Thrombin inhibitors
    申请人:Astra Aktiebolag
    公开号:EP0995755A1
    公开(公告)日:2000-04-26
    There is provided compounds of formula I,         R1O(O)C-CH2-(R)Cgl-Aze-Pab-R2     I wherein R1 and R2 have meanings given in the description, which are useful as prodrugs of inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (eg thrombosis) or as anticoagulants.
    提供了式 I 的化合物、 R1O(O)C-CH2-(R)Cgl-Aze-Pab-R2 I 其中 R1 和 R2 的含义见说明,可用作胰蛋白酶样蛋白酶(如凝血酶)抑制剂的原药,特别是用于治疗需要抑制凝血酶的病症(如血栓形成)或抗凝血剂。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物